Patent ID: 6616932
Filing Date: 2003-09-09
Classification: A61K

Abstract:
A process for administering a pharmaceutical in a pharmaceutically acceptable liquid carrier, comprising:(a) at the time of use, adding ex vivo to a pharmaceutically acceptable liquid carrier a solid unit dosage form, said solid unit dosage form comprising a substrate that disintegrates in the liquid carrier, at least one particulate pharmaceutically active material deposited on the substrate as a layer distinct from the substrate, said at least one pharmaceutically active material being present on said substrate in a pharmaceutically effective amount, and a cover sheet that disintegrates in the liquid carrier, said cover sheet being disposed over said pharmaceutically active material and sealed to said substrate, whereby said substrate and said cover sheet form an enclosure for said at least one pharmaceutically active material, and whereby said at least one pharmaceutically active material can be delivered orally in the liquid carrier in a pharmaceutically effective dosage without measuring the quantity of liquid carrier at the time of use; and (b) administering orally said at least one pharmaceutically active material and said liquid carrier to said animal.